Table 6 Molecular docking scores for curcumin, CCA-1.1, and PGV-1 against wild-type and mutant EGFR.

From: Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study

Drug

Protein

Binding Energy (kcal/Mol)

No of H bonds

Interacting amino acids (Distance)

Curcumin

EGFR (wild-type)

−11.05

1

Gln684 (2.97)

EGFR (E709K)

−11.74

3

Gly696 (2.21), Pro699 (3.08), Asn700 (3.44)

EGFR (T263P)

−10.12

2

Arg686 (2.98), Glu736 (3.19)

EGFR (V774M)

−11.94

2

Asn298 (1.84), Arg831 (2.13)

EGFR (L861Q)

−10.51

2

Arg297 (1.92), Leu707 (3.00)

CCA-1.1

EGFR (wild-type)

−12.51

2

Arg53 (1.80), Glu687 (1.79)

EGFR (E709K)

−11.02

3

Val30 (2.04), Met54 (3.76), Arg297 (1.93)

EGFR (T263P)

−11.29

1

Tyr299 (2.02)

EGFR (V774M)

−10.91

1

Val30 (2.09)

EGFR (L861Q)

−12.62

1

Val689 (3.13)

PGV-1

EGFR (wild-type)

−13.87

1

Arg686 (1.84)

EGFR (E709K)

−10.73

1

Leu777 (2.29)

EGFR (T263P)

−10.37

EGFR (V774M)

−10.58

1

Leu861 (3.09)

EGFR (L861Q)

−11.82

2

Phe723 (2.12), Lys875 (2.85)